Brain senescence spreads cell-to-cell — and an approved cancer drug interrupts it
Multiple papers converged on a single narrative: senescent brain cells recruit neighbours into senescence via paracrine signalling, with astrocytes and microglia driving the spread through CCL2, MIF, and DPP4. Separately, Sanford Burnham Prebys found that cyclin D1 accumulates in senescent cells and activates the STING inflammatory pathway. The CDK4/6 inhibitor palbociclib, already approved for breast cancer, blunted this output in aged mice.